Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
61M
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
28M
-
Shares change
-
+249K
-
Total reported value, excl. options
-
$636M
-
Value change
-
+$5.7M
-
Number of buys
-
27
-
Number of sells
-
-16
-
Price
-
$22.72
Significant Holders of PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) as of Q4 2020
58 filings reported holding PLRX - PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q4 2020.
PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28M shares
of 61M outstanding shares and own 45.92% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (5.84M shares), FMR LLC (5.32M shares), Redmile Group, LLC (3.39M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.84M shares), CHI Advisors LLC (2.35M shares), TRV GP IV, LLC (2.13M shares), CITADEL ADVISORS LLC (1.23M shares), BlackRock Inc. (856K shares), FARALLON CAPITAL MANAGEMENT LLC (764K shares), and Cormorant Asset Management, LP (611K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.